Data / Form D filings / Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc.: Form D filings
Emmaus Life Sciences, Inc., a pharmaceuticals company in Torrance, CA, filed 29 Form D notices with the SEC between 2009 and 2023. The latest, on January 31, 2023, reports an offering of $235,000 with nothing sold yet to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 21250 HAWTHORNE BLVD., SUITE 800, Torrance, CA, 90503
- Phone
- (310) 214-0065
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 822370
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | New notice | $235,000 | $0 | $235,000 | 1 | Jan 30, 2023 | sec.gov |
| Jan 20, 2023 | New notice | $34,000,000 | $0 | $34,000,000 | 3 | Jan 12, 2023 | sec.gov |
| Jun 30, 2022 | New notice | $220,000 | $110,000 | $110,000 | 1 | Jun 29, 2022 | sec.gov |
| Feb 16, 2021 | New notice | $17,000,000 | $1,920,000 | $15,080,000 | 10 | Feb 9, 2021 | sec.gov |
| Oct 9, 2020 | Amendment | $3,840,300 | $3,840,300 | 18 | Sep 22, 2020 | sec.gov | |
| Oct 7, 2020 | Amendment | $3,680,800 | $3,680,800 | 18 | Sep 22, 2020 | sec.gov | |
| Oct 7, 2020 | New notice | $3,680,800 | $0 | $3,680,800 | 18 | Sep 22, 2020 | sec.gov |
| Aug 7, 2020 | New notice | $1,895,000 | $947,600 | $947,400 | 18 | Jul 31, 2020 | sec.gov |
| Jan 8, 2016 | Amendment | $6,000,000 | $4,000,000 | $2,000,000 | 15 | Sep 22, 2014 | sec.gov |
| Jul 2, 2015 | Amendment | $3,000,000 | $2,265,000 | $735,000 | 9 | Sep 22, 2014 | sec.gov |
| Sep 30, 2014 | New notice | $2,500,000 | $1,550,000 | $950,000 | 7 | Sep 22, 2014 | sec.gov |
| Sep 30, 2014 | New notice | $1,000,000 | $260,000 | $740,000 | 6 | Jul 8, 2014 | sec.gov |
| Jan 30, 2014 | New notice | $1,000,000 | $415,000 | $585,000 | 9 | Jan 14, 2014 | sec.gov |
| Sep 17, 2013 | New notice | $2,000,000 | $221,549 | $1,778,451 | 5 | Aug 30, 2013 | sec.gov |
| Jun 14, 2013 | New notice | $2,000,000 | $72,500 | $1,927,500 | 4 | May 31, 2013 | sec.gov |
| Mar 12, 2013 | New notice | $2,500,000 | $595,000 | $1,905,000 | 16 | Feb 21, 2013 | sec.gov |
| Dec 14, 2012 | New notice | $135,846 | $135,846 | 3 | Nov 28, 2012 | sec.gov | |
| Sep 7, 2012 | New notice | $2,000,000 | $300,000 | $1,700,000 | 4 | Aug 27, 2012 | sec.gov |
| Nov 2, 2011 | New notice | $2,000,000 | $270,000 | $1,730,000 | 2 | Oct 18, 2011 | sec.gov |
| Oct 26, 2011 | New notice | Indefinite | $0 | 19 | Oct 11, 2011 | sec.gov | |
| May 9, 2011 | Amendment | $2,500,000 | $2,500,000 | 12 | Jan 20, 2011 | sec.gov | |
| Feb 17, 2011 | New notice | $5,000,000 | $450,000 | $4,550,000 | 5 | Jan 20, 2011 | sec.gov |
| Oct 18, 2010 | New notice | $3,050,000 | $1,611,688 | $1,438,312 | 4 | Oct 1, 2010 | sec.gov |
| Aug 3, 2010 | Amendment | $1,000,000 | $750,000 | $250,000 | 3 | Jun 3, 2010 | sec.gov |
| Jun 18, 2010 | New notice | $500,000 | $500,000 | 1 | Jun 3, 2010 | sec.gov | |
| Mar 18, 2010 | New notice | $1,000,000 | $1,000,000 | 1 | Jun 12, 2009 | sec.gov | |
| Mar 17, 2010 | New notice | $400,000 | $200,000 | $200,000 | 1 | May 14, 2009 | sec.gov |
| Mar 17, 2010 | New notice | $500,000 | $500,000 | 2 | Mar 30, 2009 | sec.gov | |
| Sep 8, 2009 | New notice | $6,426,000 | $2,043,000 | $4,383,000 | 6 | Aug 26, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ian Zwicker | Director | |
| Charles Stark | Executive Officer | |
| Yasushi Nagasaki | Executive Officer | |
| Wei Peu (Derek) Zen | Director | |
| Willis Lee | Executive Officer, Director | |
| George Sekulich | Executive Officer | |
| Yutaka Niihara | Executive Officer, Director | |
| Lim Seah | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jan 30, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Emmaus Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.